Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

U037 - Bureaucracy, Compliance, and Burnout: What it Means to Dermatologists

Saturday, February 17; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Examine the social, economic, and bureaucratic forces shaping the practice of dermatology in America
  • Identify the factors contributing to anxiety, frustration, and despondency for dermatologists
  • Formulate lifelong strategies to identify, prevent, and combat burnout in our specialty


This panel discussion/Q&A will analyze the factors (regulatory, social, & economic) contributing to frustration, anxiety, and despondency for dermatologists, whether employed or in private practice. We will explore what the future holds in our increasingly complex environment and discuss strategies to mitigate burnout for dermatologists.


  • Bhatia, Neal D., MD: Aclaris Therapeutics, Inc. – I(Grants/Research Funding); Actavis – I(Grants/Research Funding); Allergan, Inc – C(H); Almirall – C(H); Aqua – C(H); Asana Biosciences, LLC – I(Grants/Research Funding); Atacama Therapeutics – I(Grants/Research Funding); Bayer Pharmaceuticals – C(H); Biofrontera AG – C(H); BioPharmX – I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Cipher Pharmaceuticals – C(H); Crown Laboratories, Inc. – I(Grants/Research Funding); Cutanea Life Sciences – I(Grants/Research Funding); Dermira – I(Grants/Research Funding); DUSA Pharmaceuticals, Inc. – I(Grants/Research Funding); Ferndale Laboratories, Inc. – C(H); Foamix – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H); Glenmark Generics Inc. – I(Grants/Research Funding); IntraDerm Pharmaceuticals – C(H); ISDIN – C(H); La Roche-Posay Laboratorie Pharmaceutique – C(H); LEO Pharma, US – I(Grants/Research Funding); Mayne Pharma Group – C(H); MC2 Therapeutics – I(Grants/Research Funding); Menlo Therapeutics – I(Grants/Research Funding); Mylan Technologies Inc. – C(H); Novartis Pharmaceuticals Corp. – C(H); Ortho Dermatologics – C(H); Par Pharmaceutical – I(Grants/Research Funding); Perrigo Company – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – C(H); Promius Pharma, LLC – A(H); Realm Therapeutics – I(Grants/Research Funding); Sanofi/Regeneron – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Skinfix, Inc. – A(H); Sol-Gel Technologies – I(Grants/Research Funding); Soligenix, Inc – I(Grants/Research Funding); Strata Skin Sciences – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – C(H); Valeant Pharmaceuticals International – C(H); Viamet Pharmaceuticals, Inc – I(Grants/Research Funding); Vidac Pharma – I(Grants/Research Funding); Vyome Biosciences – I(Grants/Research Funding);
  • Kaufmann, Mark D., MD: Aclaris Therapeutics, Inc. – C(Fees); Almirall – C(Fees); Castle Biosciences, Inc – C(Fees); Dermira – C(Fees); Encore Dermatology, Inc. – C(Fees); Exeltis – C(Fees); Galderma Laboratories, L.P. – C(Fees); IntraDerm Pharmaceuticals – C(Fees); JBT Dermatology – C(Fees); Klara/Goderma, Inc. – C(SO); L'Oreal USA Inc. – C(Fees); La Roche-Posay Laboratorie Pharmaceutique – C(Fees); Menlo Therapeutics – C(Fees); Modernizing Medicine – C(SO); Ortho Dermatologics – C(Fees); Pfizer Inc. – C(Fees); Promius Pharma, LLC – C(Fees); SciBASE – C(Fees); Sensus Healthcare – C(Fees); Suneva Medical, Inc. – C(Fees);
  • Knight, J. Matthew, MD: Lumenis – I(Grants/Research Funding), SP(H);
  • Olbricht, Suzanne, MD: no financial relationships exist with commercial interests.
Saturday, February 17
4:30 PM
Dr. Knight / Intro
4:35 PM
Dr. Kaufmann / Bureaucracy & Compliance
4:50 PM
Dr. Bhatia / Social Media & Commoditization
5:00 PM
Dr. Olbricht / What do we do now?
5:10 PM
Dr. Knight / Concluding Remarks
5:15 PM
All faculty / Q&A
Event Details
  • Date
    Saturday, February 17
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 3
  • CME Credits
  • Type
    Practice Management
  • J. Matthew Knight, MD, FAAD
  • Mark D. Kaufmann, MD, FAAD - Handout
  • Neal D. Bhatia, MD, FAAD - Handout
  • Suzanne Olbricht, MD, FAAD